Biopharma

Vir, awaiting 'functional cure' data for hep B combo, w...

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis...

ElevateBio gene therapy lowers levels of toxic protein ...

ElevateBio is seeking out partnerships for its lead gene therapy after the const...

ElevateBio gene therapy lowers levels of toxic protein ...

ElevateBio is seeking out partnerships for its lead gene therapy after the const...

Cryoablation developer Adagio Medical lays off staff, r...

The cryoablation devicemaker Adagio Medical has opted to pause the European laun...

Stockpickers: Indivior highlights the difficulty of fin...

Battles with regulators, legal wrangles and threats from generic makers add to t...

Real-World Study Shows Effectiveness of Ixekizumab for ...

FRIDAY, Feb. 28, 2025 -- For patients with moderate-to-severe plaque psoriasis,...

Semaglutide May Reduce Craving in Alcohol Use Disorder

FRIDAY, Feb. 28, 2025 -- Low-dose semaglutide seems to reduce craving and certa...

Uptake of Supportive Care Low for Patients With Advance...

FRIDAY, Feb. 28, 2025 -- Many patients with advanced cancer receive potentially...

Study Explores Effect of Hybrid Closed-Loop Therapy on ...

FRIDAY, Feb. 28, 2025 -- For young people with type 1 diabetes, hybrid closed-l...

Nanosensor Assay Promising for Pancreatic Cancer Detection

FRIDAY, Feb. 28, 2025 -- A rapid nanosensor assay that measures serum protease ...

Higher Fish Intake Linked to Reduced Risk for MS Disabi...

FRIDAY, Feb. 28, 2025 -- Higher fish consumption is associated with slower disa...

Gynecological Disorders Can Increase Risk for Cardiovas...

FRIDAY, Feb. 28, 2025 -- Nonmalignant gynecological diseases (NMGD) are associa...

Patients Hospitalized With COVID-19 Face Higher Long-Te...

FRIDAY, Feb. 28, 2025 -- Individuals previously hospitalized for COVID-19 have ...

Lilly promotes ‘healthy skepticism’ toward compounded d...

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak ...

RFK Jr. moves to eliminate public comment on HHS decisions

HHS Secretary Robert F. Kennedy Jr. moved to rescind the longtime practice of gi...

Leqembi, after delay, gets back on track toward EU appr...

European regulators “reaffirmed” a positive view of Eisai and Biogen’s Alzheimer...

Praxis hits trial setback; Bristol Myers lays off staff...

The brain drug developer is continuing a trial despite a recommendation it be st...

Eli Lilly feels Magnet's pull with molecular glue deal ...

The molecular glue wave that first began years ago is still swelling, with Eli L...

BridgeBio oncology spinout to go public in blank-check ...

The deal comes amid an uptick in so-called SPAC deals, which had fallen out of f...

RFK Jr. moves to eliminate public comment in HHS decisions

HHS Secretary Robert F. Kennedy Jr. moved to rescind the longtime practice of gi...

Fierce Biotech Layoff Tracker 2025: Eisai restructures ...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

STAT+: Ginkgo further scales back Boston real estate

The once high-flying Ginkgo Bioworks is further scaling back its Boston real est...

European Shortages Monitoring Platform (ESMP) workshop ...

European Shortages Monitoring Platform (ESMP) workshop on application programmin...

Certificates Processing System: Demo & Q&A session for ...

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.